Cargando…
Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of se...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011315/ https://www.ncbi.nlm.nih.gov/pubmed/35433991 http://dx.doi.org/10.21037/atm-22-115 |
_version_ | 1784687663515697152 |
---|---|
author | Zhang, Kai Xu, Xia Hu, Lihong |
author_facet | Zhang, Kai Xu, Xia Hu, Lihong |
author_sort | Zhang, Kai |
collection | PubMed |
description | BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of sevoflurane and miR-122 in liver IR injury. METHODS: Wistar rats were divided into the following groups: sham, IR, IR + sevoflurane, IR + miR-122 antagomir, and IR + miR-122 antagomir + sevoflurane. Hematoxylin and eosin (H&E) staining and Suzuki score were used to evaluate the pathological damage of the liver. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 in the serum and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) in the liver homogenate supernatant were detected by using the corresponding kit. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) and flow cytometry was applied to evaluate the apoptosis of liver tissues. The expression of nuclear factor E2-related factor 2 (Nrf2), miR-122, p53, and HO-1 in liver tissue was evaluated by using immunohistochemistry, qRT-PCR, and western blot as needed. RESULTS: Compared to the IR group, the sevoflurane post-treatment or miR-122 antagomir groups showed improved liver injury, decreased Suzuki score, inhibited the levels of AST, ALT, LDH, MDA, NO, TNF-α, IL-1β, and IL-6, increased levels of SOD, IL-10, and inhibited hepatocyte apoptosis. Regarding the molecular mechanism, sevoflurane post-treatment fostered the expression of HO-1, promoted the transport of Nrf2 from cytoplasm to the nucleus, and decreased the expression of miR-122 and p53. The combined use of miR-122 antagomir and sevoflurane enhanced the protective effect of miR-122 antagomir in liver injury in IR rats. CONCLUSIONS: Sevoflurane protected the liver from IR damage by regulating the miR-122/Nrf2/HO-1 pathway. |
format | Online Article Text |
id | pubmed-9011315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-90113152022-04-16 Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway Zhang, Kai Xu, Xia Hu, Lihong Ann Transl Med Original Article BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of sevoflurane and miR-122 in liver IR injury. METHODS: Wistar rats were divided into the following groups: sham, IR, IR + sevoflurane, IR + miR-122 antagomir, and IR + miR-122 antagomir + sevoflurane. Hematoxylin and eosin (H&E) staining and Suzuki score were used to evaluate the pathological damage of the liver. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 in the serum and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) in the liver homogenate supernatant were detected by using the corresponding kit. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) and flow cytometry was applied to evaluate the apoptosis of liver tissues. The expression of nuclear factor E2-related factor 2 (Nrf2), miR-122, p53, and HO-1 in liver tissue was evaluated by using immunohistochemistry, qRT-PCR, and western blot as needed. RESULTS: Compared to the IR group, the sevoflurane post-treatment or miR-122 antagomir groups showed improved liver injury, decreased Suzuki score, inhibited the levels of AST, ALT, LDH, MDA, NO, TNF-α, IL-1β, and IL-6, increased levels of SOD, IL-10, and inhibited hepatocyte apoptosis. Regarding the molecular mechanism, sevoflurane post-treatment fostered the expression of HO-1, promoted the transport of Nrf2 from cytoplasm to the nucleus, and decreased the expression of miR-122 and p53. The combined use of miR-122 antagomir and sevoflurane enhanced the protective effect of miR-122 antagomir in liver injury in IR rats. CONCLUSIONS: Sevoflurane protected the liver from IR damage by regulating the miR-122/Nrf2/HO-1 pathway. AME Publishing Company 2022-03 /pmc/articles/PMC9011315/ /pubmed/35433991 http://dx.doi.org/10.21037/atm-22-115 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Zhang, Kai Xu, Xia Hu, Lihong Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title | Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title_full | Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title_fullStr | Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title_full_unstemmed | Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title_short | Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway |
title_sort | sevoflurane attenuates hepatic ischemia reperfusion injury by the mir-122/nrf2 pathway |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011315/ https://www.ncbi.nlm.nih.gov/pubmed/35433991 http://dx.doi.org/10.21037/atm-22-115 |
work_keys_str_mv | AT zhangkai sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway AT xuxia sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway AT hulihong sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway |